Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Schembl508496
2. N-benzyl-n-cyclohexylcarbodiimide
3. J3.541.507f
4. N-benzyl-n'-cyclohexylcarbodiimide, Polymer-bound 100-300 Mesh, Extent Of Labeling: ~1.3 Mmol/g N Lo ~1.3 Mmol/g N Loading
5. N-benzyl-n'-cyclohexylcarbodiimide, Polymer-bound, 100-200 Mesh, Extent Of Labeling: 1.0-2.0 Mmol/g Loading, 1 % Cross-linked With Divinylbenzene
6. N-benzyl-n'-cyclohexylcarbodiimide, Polymer-bound, 100-300 Mesh, Extent Of Labeling: ~1.3 Mmol/g N Loading
Molecular Weight | 214.31 g/mol |
---|---|
Molecular Formula | C14H18N2 |
XLogP3 | 4.6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
Exact Mass | 214.146998583 g/mol |
Monoisotopic Mass | 214.146998583 g/mol |
Topological Polar Surface Area | 24.7 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 242 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A N,N-Dicyclohexylcarbodiimide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N,N-Dicyclohexylcarbodiimide, including repackagers and relabelers. The FDA regulates N,N-Dicyclohexylcarbodiimide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N,N-Dicyclohexylcarbodiimide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N,N-Dicyclohexylcarbodiimide supplier is an individual or a company that provides N,N-Dicyclohexylcarbodiimide active pharmaceutical ingredient (API) or N,N-Dicyclohexylcarbodiimide finished formulations upon request. The N,N-Dicyclohexylcarbodiimide suppliers may include N,N-Dicyclohexylcarbodiimide API manufacturers, exporters, distributors and traders.
click here to find a list of N,N-Dicyclohexylcarbodiimide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A N,N-Dicyclohexylcarbodiimide DMF (Drug Master File) is a document detailing the whole manufacturing process of N,N-Dicyclohexylcarbodiimide active pharmaceutical ingredient (API) in detail. Different forms of N,N-Dicyclohexylcarbodiimide DMFs exist exist since differing nations have different regulations, such as N,N-Dicyclohexylcarbodiimide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N,N-Dicyclohexylcarbodiimide DMF submitted to regulatory agencies in the US is known as a USDMF. N,N-Dicyclohexylcarbodiimide USDMF includes data on N,N-Dicyclohexylcarbodiimide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N,N-Dicyclohexylcarbodiimide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N,N-Dicyclohexylcarbodiimide suppliers with USDMF on PharmaCompass.
N,N-Dicyclohexylcarbodiimide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N,N-Dicyclohexylcarbodiimide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N,N-Dicyclohexylcarbodiimide GMP manufacturer or N,N-Dicyclohexylcarbodiimide GMP API supplier for your needs.
A N,N-Dicyclohexylcarbodiimide CoA (Certificate of Analysis) is a formal document that attests to N,N-Dicyclohexylcarbodiimide's compliance with N,N-Dicyclohexylcarbodiimide specifications and serves as a tool for batch-level quality control.
N,N-Dicyclohexylcarbodiimide CoA mostly includes findings from lab analyses of a specific batch. For each N,N-Dicyclohexylcarbodiimide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N,N-Dicyclohexylcarbodiimide may be tested according to a variety of international standards, such as European Pharmacopoeia (N,N-Dicyclohexylcarbodiimide EP), N,N-Dicyclohexylcarbodiimide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N,N-Dicyclohexylcarbodiimide USP).
LOOKING FOR A SUPPLIER?